AZD-2207 is a cannabinoid receptor CB1 antagonist, known for its high lipophilicity. AZD-2207 has good intestinal permeability in the Caco-2 model and can be used in research related to type 2 diabetes and obesity[1].
Molecular Weight:
605.46
CAS Number:
[866598-45-0]
Formula:
C25H25Cl2F3N4O4S
Target:
Cannabinoid Receptor
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
